SCHEMBL4935259

SCHEMBL4935259

O=C(O)Cc1cc(Cl)c(OCc2cc(F)cc(NC3CCC3)c2)c(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
THRB P10828 6/20 0.39
THRA P10827 5/20 0.39
ALDH1A1 P00352 2/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 2/20 0.38
MAPT P10636 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
OPRK1 P41145 1/20 0.35
PPARA Q07869 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
PPARD Q03181 1/20 0.34
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34
S1PR3 Q99500 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5717820 0.91 ALDH1A1 (0.34) THRBTHRAALDH1A1HTTKMT2A
SCHEMBL4933102 0.89 ACLY (0.43) THRBTHRAALDH1A1HTTKMT2A
SCHEMBL4932002 0.89 THRB (0.50) THRBTHRA
SCHEMBL4934576 0.87 KMT2A (0.40) THRBTHRAALDH1A1HTTKMT2A
SCHEMBL4932229 0.86 PPARD (0.43) THRBTHRAPPARASMN1; SMN2PPARD
SCHEMBL4934563 0.85 PTPN1 (0.43) THRBTHRAALDH1A1KMT2AKDM4E
SCHEMBL4931877 0.85 PDE4A (0.35) ALDH1A1HTTKMT2AMAPTNPSR1
SCHEMBL5717823 0.82 MRGPRX4 (0.33) ALDH1A1HTTKMT2AMAPTNPSR1
SCHEMBL4934544 0.82 THRB (0.44) THRBTHRAKMT2AMAPTMEN1
SCHEMBL4931792 0.81 THRB (0.41) THRBTHRAPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA THRB 4/4885THRA 3/4885ALDH1A1 1818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.